1 Depto. Farmacia, CRIDECIT, FCNyCS, UNPSJB, Km. 4, (9000), Comodoro - - PowerPoint PPT Presentation

1 depto farmacia cridecit fcnycs unpsjb km 4 9000
SMART_READER_LITE
LIVE PREVIEW

1 Depto. Farmacia, CRIDECIT, FCNyCS, UNPSJB, Km. 4, (9000), Comodoro - - PowerPoint PPT Presentation

SUPRAMOLECULAR COMPLEX OF NORFLOXACIN AND SULFAMETHOXAZOLE: SYNTHESIS, CHARACTERIZATION AND EVALUATION OF THE ANTIBACTERIAL ACTIVITY Avila CD 1 , Ayala Gmez R, 1 Becerra MC 2 , Mazzieri MR 2 , Pinto Vitorino G 1 . 1 Depto. Farmacia, CRIDECIT,


slide-1
SLIDE 1

SUPRAMOLECULAR COMPLEX OF NORFLOXACIN AND SULFAMETHOXAZOLE: SYNTHESIS, CHARACTERIZATION AND EVALUATION OF THE ANTIBACTERIAL ACTIVITY Avila CD1, Ayala Gómez R,1 Becerra MC2, Mazzieri MR2, Pinto Vitorino G1.

  • 1Depto. Farmacia, CRIDECIT, FCNyCS, UNPSJB, Km. 4, (9000), Comodoro Rivadavia,
  • Chubut. 2Depto. de Ciencias Farmacéuticas, 3IMBIV-CONICET, FCQ, UNC. (5000)

Córdoba. gpinto@unpata.edu.ar

1

slide-2
SLIDE 2

SUPRAMOLECULAR COMPLEX OF NORFLOXACIN AND SULFAMETHOXAZOLE: SYNTHESIS, CHARACTERIZATION AND EVALUATION OF THE ANTIBACTERIAL ACTIVITY

2

slide-3
SLIDE 3

Fluorquinolones (FQs) and sulfonamides (SAs) are antibacterial compounds widely used in therapeutics. The combination of antibacterials is a strategy commonly employed to overcome resistance and to improve pharmacokinetic properties. So, the aims of this study were to design, prepare and characterize a multicomponent solid formed by the FQ norfloxacin (NOR) and the SA sulfamethoxazole (SMX), and to evaluate the in vitro antibacterial activity of their combinations. SMX and NOR were ground with acetonitrile. The obtained solid was analyzed by melting point (m.p), 1H MNR, Hot Stage Microscopy, Differential Scanning Calorimetry (DSC), Thermogravimetry, Powder X-ray Diffraction (PXRD) and DRIFT.1 The antibacterial effect of NOR, SMX and NOR-SMX was evaluated against Escherichia coli ATCC 25922 using the macrodilution method and checkerboard. The minimum inhibitory concentration (MIC) and the fractional inhibitory concentration (CIF) were determined.2 The solid obtained showed m.p. and DSC extrapolated onset temperatures different from NOR or SMX, and both components were present in the solid in a 1:1 ratio. The PXRD patterns demonstrated that NOR and SMX form a new solid phase. Results of the checkerboard method showed synergistic effect, with a FIC index of 0.40.3 These results are very promising so we continue developing new biopharmaceutical assays. Keywords: norfloxacin, sulfamethoxazole, supramolecular complex, synergism.

3

slide-4
SLIDE 4

4

Fluorquinolones (FQs) and sulfonamides (SAs) are antibacterial compounds widely used in therapeutics. The combination of antibacterials is a strategy commonly employed to overcome resistance and to improve pharmacokinetic properties. ❖ To design, prepare and characterize a multicomponent solid formed by the FQ norfloxacin (NOR) and the SA sulfamethoxazole (SMX). ❖ To evaluate the in vitro antibacterial activity of their combinations. Crystal engineering constitutes a potentially fruitful approach to improve the solubility, dissolution rate and bioavailability of poorly water soluble active pharmaceutical ingredients (APIs)

slide-5
SLIDE 5

5

With the aim to generate the complexes, equimolecular quantities of SMX and NOR were ground with a mortar and pestle, with the addition of acetonitrile during 30 min. ❖ melting point (m.p) ❖ 1H MNR, ❖ Hot Stage Microscopy ❖ Thermogravimetry ❖ Differential Scanning Calorimetry (DSC) ❖ Powder X-ray Diffraction (PXRD) ❖ DRIFT The obtained solid was analyzed by:

slide-6
SLIDE 6

6

The solids obtained by grinding SMX with NOR showed melting points and DSC extrapolated onset temperatures (Tonset) different from those of the starting APIs.

Muestra pf (˚C) Tonset (˚C) NOR 202,7-216,5 213,3 SMX 164,4-168,7 167,2 SMX-NOR 176,0-182,1 178,7

slide-7
SLIDE 7

7

The PXRD patterns demonstrated that the obtained sample was new solid phase.

1000 2000 3000 4000 5000 6000 5 10 15 20 25 30 35 40 45 NOR SMX

SMX-NOR

According to TLC results, both components are present in each solid, and 1H MNR data confirmed a 1:1 ratio between them

ppm (t1) 0.0 5.0 10.0 50000000 100000000 150000000 200000000 250000000 300000000 350000000 8.929 7.905 7.871 7.436 7.414 7.153 7.135 6.555 6.533 6.015 6.013 5.940 4.600 4.583 4.565 4.547 3.282 3.271 3.259 2.960 2.949 2.937 2.242 1.418 1.400 1.382 1.00 2.19

slide-8
SLIDE 8

8

1767.67 1910.24 3137.54 3461.49 500.96 528.03 757.68 805.87 870.12 1202.09 1418.94 1522.01 1705.84 2970.23 70 75 80 85 90 95 100 105 110 115 120 125 %Reflectance 500 1000 1500 2000 2500 3000 3500 Wavenumbers (cm-1)

This results indicate that NOR pure predominate in the zwitterionic form and in the complexes is present as neutral specie, probably forming hydrogen bonding with the H atom of the SO2NH group of the SA. By comparing the DRIFT spectra of SMX-NOR (red) with those of the pure NOR (blue) and SMX (purple), the major differences were: a) a new peak at 1705 cm-1 attributable to the presence of the COOH group of NOR and the lack of the peaks at 1590 cm-1 (COO-) and 2550 cm-1 (NH2), b) the absence of the peak at 3461 cm-1 attributable to the NH stretching of SMX.

slide-9
SLIDE 9

9

For antimicrobial activity determinations against Escherichia coli ATCC 25922, MIC values of NOR and SMX were determined by using the macrodilution method with Mueller–Hinton broth. MICs were measured by triplicate and determined according to CLSI recommendations. The MIC was defined as the lowest concentration of antibiotic that inhibited all visible growth.

MIC

slide-10
SLIDE 10

10

To evaluate the synergistic effect of the combination by checkerboard, the Fractional Inhibitory Concentration (FIC) was calculated for the NOR-SMX combination as:

slide-11
SLIDE 11

11 ANTIBIOTICS ANTIBACTERIAL CLASS TARGET MIC (μg/mL) NOR-SMX FIC INDEX NOR Fluorquinolone Enzymes: DNA gyrase and Topoisomerase IV 0,1 -0,06 0,4 SMX Sulfonamide Enzyme: dihydrofolate reductase 250-125

The minimum FIC between all of the calculated FICs was defined as FIC index. The

  • btained values of the FIC index were assigned according to the following table 1.

ANTIBACTERIAL EFECT FIC INDEX synergism <0.5 partial synergism 0,5-1 indifference 1-4 Antagonism >4

The results obtained from the MIC and FIC index are expressed in the table 2 : These results are very promising, considering that CIF values lower than 0.5 indicate that the in vitro antibacterial activity of the mixture is better than each ATB individually.

slide-12
SLIDE 12

❖ By liquid assisted grinding, it was possible to obtain a new molecular complexes

  • riginated from the interaction in the solid state between NOR and SMX.

❖ The in vitro antibacterial activity of the combination NOR-SMX against E. coli 25922 was

  • synergistic. There are several possible mechanisms to generate synergistic effect, one of

which is that both groups of ATB acts at different levels of DNA synthesis, exerting a cooperative effect.

12

slide-13
SLIDE 13

❖ The complex presented an 1:1 stoichiometry. According to DRIFT data, the interaction would occur between the COOH of NOR and the SO2NH group of the sulfonamide (the methoxazol of SMX could be involved as well).

13

slide-14
SLIDE 14

1.- Pinto Vitorino, G.; Sperandeo, N. R.; Caira, M.; Mazzieri, M. R. Crystal Growth & Design, 13: 1050-58. 2013. 2.- Eliopoulos GM, Moellering Jr RC. Antimicrobial combinations. En: Lorian V, editor. Antibiotics in laboratory medicine, 4 ed. Baltimore, Md: The Williams & Wilkins Co. 1996. 3.- Pinto Vitorino G, Becerra MC, Barrera GD, Caira MR, Mazzieri MR. Biological and Pharmaceutical Bulletin, 2017, 40, 758–764.

14

slide-15
SLIDE 15

The authors acknowledge financial support from CONICET and UNPSJB.

15